Whales with a lot of money to spend have taken a noticeably bullish stance on Cardinal Health. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened ...

Cencora COR saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 78. Please watch ...

Major indices were in the green at the opening bell on Tuesday as traders digested last month's consumer price index.

CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) posted higher revenue and profits in its fiscal third quarter, driven by growth ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that ...

Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.